OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+5.72%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$824M
AUM Growth
+$824M
(+4.6%)
Cap. Flow
+$10.6M
Cap. Flow
% of AUM
1.29%
Top 10 Holdings %
Top 10 Hldgs %
72.89%
Holding
30
New
2
Increased
8
Reduced
10
Closed
3
Top Buys
| 1 |
AGEN
Agenus
AGEN
|
$20.8M |
| 2 |
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
|
$17.3M |
| 3 |
Precigen
PGEN
|
$8.97M |
| 4 |
CFRX
ContraFect Corporation
CFRX
|
$6.21M |
| 5 |
MZOR
Mazor Robotics Ltd.
MZOR
|
$3.21M |
Top Sells
| 1 |
YTEN
Yield10 Bioscience, Inc. Common Stock
YTEN
|
$22.9M |
| 2 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$7.63M |
| 3 |
RGLS
Regulus Therapeutics
RGLS
|
$5.98M |
| 4 |
Abeona Therapeutics
ABEO
|
$4.24M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$3.73M |
Sector Composition
| 1 | Healthcare | 75.91% |
| 2 | Consumer Staples | 0.52% |
| 3 | Financials | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXDX
1
DELISTED
Accelerate Diagnostics
AXDX
| $140M | 16.99% |
5,425,893
| – | – |
|
2
Opko Health
OPK
$1.1B
| $79.7M | 9.68% |
4,959,335
| – | – |
|
3
QuidelOrtho
QDEL
$1.95B
| $66.5M | 8.06% |
2,895,808
-19,825
| -0.7% | -$455K |
|
|
THOR
4
DELISTED
THORATEC CORPORATION
THOR
| $54.8M | 6.65% |
1,229,600
-3,000
| -0.2% | -$134K |
|
|
NXTM
5
DELISTED
NxStage Medical Inc.
NXTM
| $51M | 6.19% |
3,572,963
-181,380
| -5% | -$2.59M |
|
|
CMRX
6
DELISTED
Chimerix, Inc.
CMRX
| $47.4M | 5.75% |
1,025,921
+62,023
| +6% | +$2.87M |
|
|
7
Precigen
PGEN
$1.34B
| $42.8M | 5.19% |
876,502
+183,908
| +27% | +$8.97M |
|
|
HNSN
8
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
| $41.1M | 4.99% |
44,918,191
+18,890,210
| +73% | +$17.3M |
|
|
MZOR
9
DELISTED
Mazor Robotics Ltd.
MZOR
| $32.5M | 3.94% |
2,439,237
+240,967
| +11% | +$3.21M |
|
|
AGEN
10
Agenus
AGEN
$133M
| $30.9M | 3.75% |
3,579,592
+2,414,408
| +207% | +$20.8M |
|
|
TSRO
11
DELISTED
TESARO, Inc.
TSRO
| $29M | 3.52% |
493,000
-63,379
| -11% | -$3.73M |
|
|
ACOR
12
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $27.2M | 3.3% |
815,838
-228,945
| -22% | -$7.63M |
|
13
Accuray
ARAY
$157M
| $21.4M | 2.6% |
3,176,838
-189,378
| -6% | -$1.28M |
|
14
Pacific Biosciences
PACB
$393M
| $18.7M | 2.27% |
3,241,761
-43,035
| -1% | -$248K |
|
|
BIOL
15
DELISTED
Biolase, Inc.
BIOL
| $18.2M | 2.21% |
10,474,725
| – | – |
|
|
VRML
16
DELISTED
Vermillion, Inc.
VRML
| $16.8M | 2.04% |
8,112,182
| – | – |
|
|
AMRN
17
Amarin Corp
AMRN
$311M
| $12.8M | 1.55% |
5,184,225
+52,781
| +1% | +$130K |
|
|
WBMD
18
DELISTED
WebMD Health Corp.
WBMD
| $10.5M | 1.28% |
238,103
| – | – |
|
|
TTHI
19
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
| $10.2M | 1.24% |
4,863,914
+2,593
| +0.1% | +$5.45K |
|
|
RGLS
20
DELISTED
Regulus Therapeutics
RGLS
| $8.13M | 0.99% |
741,804
-545,346
| -42% | -$5.98M |
|
|
CFRX
21
DELISTED
ContraFect Corporation
CFRX
| $6.21M | 0.75% |
+1,182,032
| New | +$6.21M |
|
|
YTEN
22
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $4.33M | 0.52% |
1,153,592
-6,104,514
| -84% | -$22.9M |
|
23
Biogen
BIIB
$19.4B
| $3.12M | 0.38% |
7,723
| – | – |
|
24
Alaunos Therapeutics
TCRT
$4.21M
| $2.91M | 0.35% |
+242,168
| New | +$2.91M |
|
25
Vivani Medical
VANI
$68.1M
| $2.86M | 0.35% |
210,000
| – | – |
|